BRAF and neoplasm: Indeed, tumours carrying somatic mutations in BRAF and RET genes (constituting the BRAF-like subtype) exhibit a marked ERK-induced transcriptional signature which allows them to escape from the canonical ERK inhibitory feedback [1, 2].